MMP2 and urinary bladder carcinoma: In consistent with four studies performing DFS/RFS analysis, Olsson et al. reported that abnormal expression of MMP2 and MMP9 were associated with a high risk of tumor recurrence in patients with stage T1 bladder cancer [41].